2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Trauma: new trials by email Literature Review of Trauma trials Research Report on Trauma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Empiric Calcium in Massive Transfusion Calcium Gluconate - Hemorrhage, Trauma | Phase 3 | Withdrawn | University of California, Irvine | 2025-01-01 | 2026-03-30 | |
| Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma activated recombinant human factor VII - Acquired Bleeding Disorder, Trauma | Phase 3 | Withdrawn | Novo Nordisk A/S | 2006-05-01 | 2012-06-27 |
Wounds and Injuries (2) · Hemorrhage (1) · Hypocalcemia (1) · Shock, Hemorrhagic (1)
Calcium Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Shock (1) · Water-Electrolyte Imbalance (1)
Calcium (1) · Calcium Gluconate (1)
Novo Nordisk A/S (1) · University of California, Irvine (1)
United States (1)
Bartholomew Tortella, MD (1) · Jeffry Nahmias, MD (1)